Related Experiment Videos

Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization

A Kvanta1, W Y Shen, S Sarman

  • 1Department of Ophthalmology, St. Erik's Eye Hospital, Karolinska Institutet, Stockholm, Sweden. ankvanta@swipnet.se

Current Eye Research
|December 20, 2000
PubMed
Abstract

Insights

Matrix metalloproteinase-2 (MMP-2) mRNA expression significantly increases in experimental choroidal neovascularization (CNV) in rats. This finding supports MMP-2

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) are enzymes degrading extracellular matrix.
  • MMP-2 and MMP-9 are implicated in ocular neovascularization.
  • Choroidal neovascularization (CNV) is a key feature of age-related macular degeneration.

Purpose of the Study:

  • To investigate the role of MMP-2 and MMP-9 in experimental CNV.
  • To analyze the mRNA expression of MMP-2 and MMP-9 in a rat model of CNV.

Main Methods:

  • CNV was induced in rats using krypton laser photocoagulation.
  • Eyes were enucleated at various time points (1-60 days).
  • In situ hybridization was used to analyze MMP-2 and MMP-9 mRNA expression.

Main Results:

  • MMP-2 mRNA expression was low in untreated eyes but markedly increased in laser-treated eyes.
  • Increased MMP-2 mRNA was localized to macrophage-like and RPE-like cells.
  • MMP-2 mRNA expression peaked at day 10 post-laser treatment.
  • MMP-9 mRNA expression remained low and did not increase after laser treatment.

Conclusions:

  • MMP-2 mRNA expression is upregulated in experimental CNV.
  • These findings support a role for MMP-2 in the pathogenesis of CNV.
  • MMP-2 may be a therapeutic target for age-related macular degeneration.

Related Concept Videos